Lax testing fuelled wave of cough syrup poisonings

In December 2019, tragedy struck the Himalayan mountains as Jafar Din's two-month-old son, Irfan, fell ill. Desperate to save him, Din bought COLDBEST-PC medicine from a local pharmacy. Tragically, Irfan's condition worsened, and he died. This incident triggered a global wave of poisonings linked to cough syrups, highlighting lax manufacturing practices and regulatory shortcomings in India's pharmaceutical industry.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news